(Q53668348)

17 May 2018

title

Deficiency of von Willebrand factor-cleaving protease activity in the plasma of malignant patients. (English)

1 reference

17 May 2018

author

Nam Keun Kim

4

1 reference

17 May 2018

author name string

Bon-Hun Koo

1

1 reference

17 May 2018

Doyeun Oh

2

1 reference

17 May 2018

So Young Chung

3

1 reference

17 May 2018

Seonyang Park

5

1 reference

17 May 2018

Yangsoo Jang

6

1 reference

17 May 2018

Kwang-Hoe Chung

7

1 reference

17 May 2018

publication date

1 March 2002

1 reference

17 May 2018

published in

Thrombosis Research

1 reference

17 May 2018

volume

105

1 reference

17 May 2018

issue

6

1 reference

17 May 2018

page(s)

471-476

1 reference

17 May 2018

Inducible secretion of large, biologically potent von Willebrand factor multimers

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900053-1

7 January 2021

Binding of von Willebrand factor to glycoproteins Ib and IIb/IIIa complex: affinity is related to multimeric size

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900053-1

7 January 2021

Venom coagglutinin: an activator of platelet aggregation dependent on von Willebrand factor

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900053-1

7 January 2021

Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900053-1

7 January 2021

Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900053-1

7 January 2021

Increased von Willebrand factor binding to platelets in single episode and recurrent types of thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900053-1

7 January 2021

A new mechanism for tumor-induced platelet aggregation. Comparison with mechanisms shared by other tumors with possible pharmacologic strategy toward prevention of metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900053-1

7 January 2021

Tumor-induced platelet aggregation and growth promoting factors as determinants for successful tumor metastasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900053-1

7 January 2021

Murine tumor-induced platelet aggregation and coagulation: mechanisms, inhibitors, and species differences

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900053-1

7 January 2021

Characterization of tumor-induced platelet aggregation: the role of immunorelated GPIb and GPIIb/IIIa expression by MCF-7 breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900053-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900053-1

7 January 2021

Human breast carcinoma cells synthesize a protein immunorelated to platelet glycoprotein-Ib alpha with different functional properties

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900053-1

7 January 2021

Platelet-tumor cell interaction with the subendothelial extracellular matrix: relationship to cancer metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900053-1

7 January 2021

Microangiopathic haemolytic anaemia in metastasizing malignant tumours is not associated with a severe deficiency of the von Willebrand factor-cleaving protease.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900053-1

7 January 2021

von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900053-1

7 January 2021

Unusually large plasma factor VIII:von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900053-1

7 January 2021

Calpain proteolysis of von Willebrand factor enhances its binding to platelet membrane glycoprotein IIb/IIIa: an explanation for platelet aggregation in thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900053-1

7 January 2021

A cathepsin-like cysteine proteinase proaggregating activity in thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900053-1

7 January 2021

Effects of plasmin on von Willebrand factor multimers. Degradation in vitro and stimulation of release in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900053-1

7 January 2021

Endothelial cell-derived high molecular weight von Willebrand factor is converted into the plasma multimer pattern by granulocyte proteases

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900053-1

7 January 2021

10.1016/S0049-3848(02)00053-1

Identifiers

DOI

1 reference

17 May 2018

1 reference

17 May 2018